(Q39826620)

15 September 2017

1 reference

title

Neuropharmacological profile of cholecystokinin-like peptides (English)

1 reference

15 September 2017

1 reference

Zetler G

1

1 reference

PubMed ID

3896097

15 September 2017

language of work or name

English

0 references

publication date

1 January 1985

1 reference

Annals of the New York Academy of Sciences

15 September 2017

1 reference

15 September 2017

448

1 reference

15 September 2017

448-469

1 reference

Effects of cholecystokinin-like peptides on rearing activity and hexobarbital-induced sleep.

15 September 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Neuroleptic-like effects of ceruletide and cholecystokinin octapeptide: interactions with apomorphine, methylphenidate and picrotoxin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin-octapeptide effects on conditioned-avoidance behavior, stereotypy and catalepsy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

In rats, the behavioral profile of CCK-8 related peptides resembles that of antipsychotic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Neuropeptide modulation of social and exploratory behaviors in laboratory rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin reduces exploratory behavior in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Divergent effects of cholecystokinin, bombesin, and lithium on rat exploratory behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin accelerates the rate of habituation to a novel environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Nucleus tractus solitarius lesions block the behavioral actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Effects of systemically administered cholecystokinin-octapeptide on local cerebral metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

The role of central and peripheral cholecystokinin in mediating appetitive behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Electroencephalographic analysis of the sleep-inducing actions of cholecystokinin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Central depressant effects of caerulein and cholecystokinin octapeptide (CCK-8) differ from those of diazepam and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on motor behaviour, hexobarbital-induced sleep and harman-induced convulsions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Long-lasting reduction of amphetamine-induced hyperactivity in rats after combined administration of caerulein with haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin decreases appetite and activation evoked by stimuli arising from the preparation of a meal in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin octapeptide decreases intake of solid food in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Ceruletide decreases food intake in non-obese man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Effect of ceruletide on pituitary-hypothalamic peptides and on emotion in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Caerulfin and cholecystokinin octapeptide (CCK-8): Sedative and anticonvulsive effects in mice unaffected by the benzodiazepine antagonist Ro 15-1788

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and clonazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Functional characterization of central α-adrenoceptors by yohimbine diastereomers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Selective stimulation of dopamine and noradrenaline autoreceptors by B-HT 920 and B-HT 933, respectively

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Caerulein and morphine: an attempt to differentiate their antinociceptive effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Predictability and specificity of behavioral screening tests for nucleoleptics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Potentiation of apomorphine-induced gnawing in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Anticonvulsant effects of caerulein and cholecystokinin octapeptide, compared with those of diazepam

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Anticonvulsant effects of caerulein, cholecystokinin octapeptide (CCK-8) and diazepam against seizures produced in mice by harman, thiosemicarbazide and isoniazid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Molecular Mechanisms in the Receptor Action of Benzodiazepines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

1-Methyl-?-carboline (Harmane), a potent endogenous inhibitor of benzodiazepine receptor binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Structure-activity and dose-effect relationships of the antagonism of picrotoxin-induced seizures by cholecystokinin, fragments and analogues of cholecystokinin in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Endogenous opiods may mediate post-ictal behavioral depression in amygdaloid-kindled rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Studies on the post-ictal rise in seizure threshold

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Opiate-like electroencephalographic and behavioral effects of electroconvulsive shock in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Inhibition of seizures induced by picrotoxin and electroshock by cholecystokinin octapeptides and their fragments in rats after intracerebroventricular administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

The effects of sulfated and nonsulfated cholecystokinin octapeptides on electroconvulsive shock-induced retrograde amnesia after. Intracerebroventricular administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Caerulein and morphine in a model of visceral pain. Effects on the hypotensive response to renal pelvis distension in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Apomorphine separates the antinociceptive effects of cholecystokinin octapeptide and ceruletide from those of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Evidence for the Neuropeptide Cholecystokinin as an Antagonist of Opiate Analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Proglumide prevents and curtails acute tolerance to morphine in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Effect of ceruletide on rest pain in patients with arterial insufficiency of the lower extremity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Ceruletide increases threshold and tolerance to experimentally induced pain in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Ceruletide increases dose dependently both jejunal motor activity and threshold and tolerance to experimentally induced pain in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin-induced hypothermia in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Central administration of peptides alters thermoregulation in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin-octapeptide-induced hyperthermia in guinea-pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Further analysis of the effects of cholecystokinin octapeptides on avoidance behaviour in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Tolerance to the anti-avoidance properties of cholecystokinin-octapeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Influence of sulfated and unsulfated cholecystokinin octapeptide on conditioned feeding behaviour in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Intravenous cholecystokinin octapeptide in pigs reduces operant responding for food, water, sucrose solution or radiant heat

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Hypothalamic and locus coeruleus self-stimulation are decreased by cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin tetrapeptide, proglumide and open-field behavior in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Facilitation of GABA release by cholecystokinin and caerulein in rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Ceruletide, ceruletide analogues and cholecystokinin octapeptide (CCK-8): effects on isolated intestinal preparations and gallbladders of guinea pigs and mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

The manifold actions of neurotensin: a first synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Blood-brain barrier restriction of peptides and the low uptake of enkephalins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Caerulein, a cholecystokinin-related peptide, depresses somatic function via the vagal afferent system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin appears to have antipsychotic properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Reduction in cholecystokinin-like immunoreactivity in the basal ganglia in Huntington's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Cholecystokinin receptors are decreased in basal ganglia and cerebral cortex of Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

CCK receptors and human neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

CCK-8-immunoreactivity distribution in human brain: selective decrease in the substantia nigra from parkinsonian patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

Rapid development of tolerance to the behavioural actions of cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1749-6632.1985.TB29940.X

10.1111/J.1749-6632.1985.TB29940.X

21 January 2018

Identifiers

DOI

1 reference

15 September 2017

1 reference

PubMed ID

3896097